CA Stock MarketDetailed Quotes

GTTX GeneTether Therapeutics Inc

Watchlist
  • 0.120
  • 0.0000.00%
15min DelayMarket Closed Jan 7 11:43 ET
4.65MMarket Cap-8.57P/E (TTM)

GeneTether Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
212.29%134.94K
-23.59%116.98K
-24.90%159.1K
-56.48%747.28K
-11.39%339.23K
-89.21%43.21K
-66.48%153.1K
-55.63%211.83K
4.91%1.72M
-31.71%382.82K
Selling and administrative expenses
316.24%134.17K
-22.56%106.99K
-25.10%147.88K
-53.47%551.07K
-19.43%183.32K
-87.89%32.23K
-57.86%138.16K
-45.60%197.44K
-3.87%1.18M
-36.91%227.52K
-General and administrative expense
316.24%134.17K
-22.56%106.99K
-25.10%147.88K
-53.47%551.07K
-19.43%183.32K
-87.89%32.23K
-57.86%138.16K
-45.60%197.44K
-3.87%1.18M
-36.91%227.52K
Research and development costs
-92.96%773
-33.08%9.99K
-22.08%11.21K
-63.18%196.21K
0.40%155.91K
-91.83%10.98K
-88.41%14.94K
-87.43%14.39K
31.61%532.84K
-22.35%155.3K
Operating profit
-212.29%-134.94K
23.59%-116.98K
24.90%-159.1K
56.48%-747.28K
11.39%-339.23K
89.21%-43.21K
66.48%-153.1K
55.63%-211.83K
-4.91%-1.72M
31.71%-382.82K
Net non-operating interest income (expenses)
-59.56%6.2K
-32.30%9.05K
94.42%15.09K
977.64%52.16K
15.69K
15.34K
13.37K
7.76K
1,816.31%4.84K
Non-operating interest income
-59.56%6.2K
-32.30%9.05K
94.42%15.09K
977.64%52.16K
--15.69K
--15.34K
--13.37K
--7.76K
--4.84K
----
Other net income (expenses)
-98.64%4
129.15%144
40.45%-212
336.53%6.76K
1,340.16%7.32K
125.86%294
-1,108.16%-494
84.37%-356
-623.54%-2.86K
508
Gain on sale of security
-98.64%4
129.15%144
40.45%-212
336.53%6.76K
1,340.16%7.32K
125.86%294
-1,108.16%-494
84.37%-356
-623.54%-2.86K
--508
Income before tax
-366.76%-128.73K
23.13%-107.79K
29.45%-144.22K
59.87%-688.36K
16.23%-316.22K
93.13%-27.58K
69.29%-140.22K
57.38%-204.43K
-4.74%-1.72M
32.71%-377.47K
Income tax
Earnings from equity interest net of tax
Net income
-366.76%-128.73K
23.13%-107.79K
29.45%-144.22K
59.87%-688.36K
16.23%-316.22K
93.13%-27.58K
69.29%-140.22K
57.38%-204.43K
-4.74%-1.72M
32.71%-377.47K
Net income continuous operations
-366.76%-128.73K
23.13%-107.79K
29.45%-144.22K
59.87%-688.36K
16.23%-316.22K
93.13%-27.58K
69.29%-140.22K
57.38%-204.43K
-4.74%-1.72M
32.71%-377.47K
Noncontrolling interests
Net income attributable to the company
-366.76%-128.73K
23.13%-107.79K
29.42%-144.22K
59.87%-688.36K
16.23%-316.22K
93.13%-27.58K
69.29%-140.22K
57.40%-204.34K
-4.74%-1.72M
32.71%-377.47K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-366.76%-128.73K
23.13%-107.79K
29.42%-144.22K
59.87%-688.36K
16.23%-316.22K
93.13%-27.58K
69.29%-140.22K
57.40%-204.34K
-4.74%-1.72M
32.71%-377.47K
Diluted earnings per share
-489.18%-0.0033
3.77%-0.0028
11.82%-0.0037
75.00%-0.01
0
94.36%-0.0006
71.09%-0.0029
57.79%-0.0042
-12.37%-0.04
17.99%-0.01
Basic earnings per share
-489.18%-0.0033
3.77%-0.0028
11.82%-0.0037
75.00%-0.01
0
94.36%-0.0006
71.09%-0.0029
57.79%-0.0042
-12.37%-0.04
17.99%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense 212.29%134.94K -23.59%116.98K -24.90%159.1K -56.48%747.28K -11.39%339.23K -89.21%43.21K -66.48%153.1K -55.63%211.83K 4.91%1.72M -31.71%382.82K
Selling and administrative expenses 316.24%134.17K -22.56%106.99K -25.10%147.88K -53.47%551.07K -19.43%183.32K -87.89%32.23K -57.86%138.16K -45.60%197.44K -3.87%1.18M -36.91%227.52K
-General and administrative expense 316.24%134.17K -22.56%106.99K -25.10%147.88K -53.47%551.07K -19.43%183.32K -87.89%32.23K -57.86%138.16K -45.60%197.44K -3.87%1.18M -36.91%227.52K
Research and development costs -92.96%773 -33.08%9.99K -22.08%11.21K -63.18%196.21K 0.40%155.91K -91.83%10.98K -88.41%14.94K -87.43%14.39K 31.61%532.84K -22.35%155.3K
Operating profit -212.29%-134.94K 23.59%-116.98K 24.90%-159.1K 56.48%-747.28K 11.39%-339.23K 89.21%-43.21K 66.48%-153.1K 55.63%-211.83K -4.91%-1.72M 31.71%-382.82K
Net non-operating interest income (expenses) -59.56%6.2K -32.30%9.05K 94.42%15.09K 977.64%52.16K 15.69K 15.34K 13.37K 7.76K 1,816.31%4.84K
Non-operating interest income -59.56%6.2K -32.30%9.05K 94.42%15.09K 977.64%52.16K --15.69K --15.34K --13.37K --7.76K --4.84K ----
Other net income (expenses) -98.64%4 129.15%144 40.45%-212 336.53%6.76K 1,340.16%7.32K 125.86%294 -1,108.16%-494 84.37%-356 -623.54%-2.86K 508
Gain on sale of security -98.64%4 129.15%144 40.45%-212 336.53%6.76K 1,340.16%7.32K 125.86%294 -1,108.16%-494 84.37%-356 -623.54%-2.86K --508
Income before tax -366.76%-128.73K 23.13%-107.79K 29.45%-144.22K 59.87%-688.36K 16.23%-316.22K 93.13%-27.58K 69.29%-140.22K 57.38%-204.43K -4.74%-1.72M 32.71%-377.47K
Income tax
Earnings from equity interest net of tax
Net income -366.76%-128.73K 23.13%-107.79K 29.45%-144.22K 59.87%-688.36K 16.23%-316.22K 93.13%-27.58K 69.29%-140.22K 57.38%-204.43K -4.74%-1.72M 32.71%-377.47K
Net income continuous operations -366.76%-128.73K 23.13%-107.79K 29.45%-144.22K 59.87%-688.36K 16.23%-316.22K 93.13%-27.58K 69.29%-140.22K 57.38%-204.43K -4.74%-1.72M 32.71%-377.47K
Noncontrolling interests
Net income attributable to the company -366.76%-128.73K 23.13%-107.79K 29.42%-144.22K 59.87%-688.36K 16.23%-316.22K 93.13%-27.58K 69.29%-140.22K 57.40%-204.34K -4.74%-1.72M 32.71%-377.47K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -366.76%-128.73K 23.13%-107.79K 29.42%-144.22K 59.87%-688.36K 16.23%-316.22K 93.13%-27.58K 69.29%-140.22K 57.40%-204.34K -4.74%-1.72M 32.71%-377.47K
Diluted earnings per share -489.18%-0.0033 3.77%-0.0028 11.82%-0.0037 75.00%-0.01 0 94.36%-0.0006 71.09%-0.0029 57.79%-0.0042 -12.37%-0.04 17.99%-0.01
Basic earnings per share -489.18%-0.0033 3.77%-0.0028 11.82%-0.0037 75.00%-0.01 0 94.36%-0.0006 71.09%-0.0029 57.79%-0.0042 -12.37%-0.04 17.99%-0.01
Dividend per share
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- Unqualified Opinion --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.